Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Key Players companies in Nicotinamide mononucleotide
by Most Research Publications in the United States in 2018

The Nicotinamide mononucleotide top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Research Publications Nicotinamide mononucleotide Key Players in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Nicotinamide mononucleotide ("NMN", "NAMN", and "β-NMN") is a nucleotide derived from ribose and nicotinamide. Like nicotinamide riboside, NMN is a derivative of niacin, and humans have enzymes that can use NMN to generate nicotinamide adenine dinucleotide (NADH).
#
Company Name
Region
Tech Topics
Total
1
Health care,Mitral valve surgery,Health equity,
...[+2]
Literature: 2
2
Health care,National security,Health Insurance Portability and Accountability Act,
...[+2]
Literature: 2
3
Literature: 1
4
Literature: 1
5
Literature: 1
6
Health care,Trauma center,Patient education,
...[+2]
Literature: 1
7
Medical school,Clinical research,Health care,
...[+2]
Literature: 1
8
Research Triangle Foundation
Science park
Literature: 1
9
Literature: 1
10
Jules Stein Eye Institute
Social network,Health care,Ophthalmology,
...[+2]
Literature: 1
Page generation time: Jun 24 2025